For as many as one in five Australians, the use of continuous positive airway pressure (CPAP) treatment for sleep apnoea is now a part of their nightly routine. Where ever they plan to lay their heads ...
MUNICH--(BUSINESS WIRE)--ResMed (NYSE: RMD) (ASX: RMD), the world’s leading tech-driven medical company and innovator in sleep apnea and respiratory care, today announced the results of a court and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results